I Dewa Ayu Agung Sridharaswari
Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya/Hematology Oncology Division, Department of Child Health, Dr. Soetomo General Academic Hospital, Surabaya

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Discriminative Performance of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Differentiating Acute Lymphoblastic Leukemia From Myeloid Leukemia in Children I Dewa Ayu Agung Sridharaswari; Mia Ratwita Andarsini; Maria Christina Shanty Larasati; I Dewa Gede Ugrasena; I Gusti Agung Ayu Putri Sri Rejeki
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2964

Abstract

Early differentiation between Acute Lymphoblastic Leukemia (ALL) and myeloid leukemia is clinically important because therapeutic strategies differ substantially. Definitive diagnosis requires bone marrow examination supported by immunophenotyping. However, complete blood count (CBC) parameters are usually available earlier in the initial evaluation. Hematologic ratios derived from CBC, such as the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), may provide supportive information during early clinical assessment. To evaluate the discriminative performance of NLR and PLR in differentiating pediatric ALL from myeloid leukemia. A retrospective cross-sectional study was conducted using medical records of children aged 0–18 years with leukemia, which had been confirmed by bone marrow examination at a tertiary referral hospital. Neutrophil-to-lymphocyte ratio (NLR) and PLR were analyzed as continuous variables using Receiver Operating Characteristic (ROC) curve analysis. Optimal cut-off values were determined using Youden’s Index. Logistic regression analysis was performed to evaluate the association between these ratios and the ALL status. A total of 506 pediatric leukemia cases were included (428 ALL and 78 myeloid leukemia). The Median of NLR was significantly lower in ALL compared to myeloid leukemia (0.11 vs 1.09; p <0.001). The NLR demonstrated good discriminative ability with an AUC of 0.869 (95% CI 0.823–0.914). The optimal cut-off value of 0.415 yielded 82.7% sensitivity and 76.9% specificity. In multivariate analysis, lower NLR remained independently associated with ALL (OR 0.811; 95% CI 0.693–0.951; p =0.010). platelet-to-lymphocyte ratio (PLR) showed modest discrimination (AUC 0.611) and did not retain independent significance after adjustment. Neutrophil-to-lymphocyte ratio (NLR) demonstrates good discriminative performance for differentiating ALL from myeloid leukemia and may serve as a supportive triage parameter during initial evaluation. However, it should not replace standard diagnostic procedures such as bone marrow examination and immunophenotyping.